Subcutaneous Interleukin-4 for Relapsed Non-Hodgkin's Lymphoma: A Phase Ii Trial in the North Central Cancer Treatment Group, Ncctg 91-78-51
Journal of Investigative Medicine | January 6, 2023 | Volume: 55 | Issue: 2 | Pages: 362-362
10.1177/108155890705500281